Healthcare Executive Matthew Nienaber Joins BoCG Ventures as Entrepreneur-in-Residence

Seasoned healthcare professional and entrepreneur brings expertise to medical, healthcare, and wellness vertices

Los Angeles, CA — BoCG Ventures (BoCGV), a leading Venture Operating Firm that builds, operates, and invests in high-growth, innovative companies announced today that Matthew Nienaber has joined the firm as a Entrepreneur-in-Residence (EIR). In this role, Nienaber will pursue a hands-on role with healthcare-related portfolio and venture clients focusing on healthtech, medtech, insurtech, and digital health technologies.

As part of his mandate, Nienaber will oversee diligence, validation, and venture support for potential healthcare related projects at BoCG Ventures. More specifically, Matthew aims to educate healthcare professionals on wealth building through investing in the future of healthcare innovation and the Fund’s portfolio assets.

“As a practicing physician, I know first hand how much healthcare professionals miss out on trends in innovation, and investment opportunities that impact patient care. BoCG Ventures offers a direct window into new technologies where I can provide feedback from a practitioner and patient view, says Nienaber.” More importantly, “I see diversifying investments into alternative vehicles such as BoCG Ventures as a vital step for healthcare professionals to participate in the future of care. I am thrilled to be a part of building out BoCG Ventures’ Venture Operating Model portfolio, Fund directives, and overall influence in the industry.”

“As both an entrepreneur and a healthcare leader, Matthew has an impressive history of working outside the box,” said Lyon Kassab, Managing Partner at BoCG Ventures. “With an increase in competitive markets, we need seasoned multidisciplinary professionals with deep relationships to further differentiate and create influence in local communities. We are pleased to welcome Matthew to the team and look forward to adding his expertise and influence to our investment approach.”

Matthew Nienaber is an Internal Medicine Physician based in Los Angeles and comes with a decade of experience; he has dedicated himself to innovative medical services, healthcare delivery models, as well as international clinical work. BoCG Ventures is an active Venture Operating Firm currently working with healthtech, nanobiotechnology, and digital health clients. With the addition of Nienaber, the firm aims to bolster both the medical communities’ role in healthcare investing as well as commercializing spinouts into the private sector.

About BoCG Ventures: BoCG Ventures is focused on designing companies that endure past tomorrow. It is the only antifragile fund that employs a hands-on operational framework (VOM) to pinpoint innovative solutions for those who value data-driven growth in both local and global markets to achieve scale and enduring returns. To learn more, visit www.bocgventures.com.

Contacts: Media Contact: ir@bocgventures.com | Chris Ha: chris@bocgventures.com

To stay connected, follow us on LinkedIn, Medium, and Twitter.

_________________________________________________________

The views expressed here are those of the individual BoCG Ventures, L.L.C. (“BV”) personnel quoted and are not the views of BV or its affiliates. Certain information contained in here has been obtained from third-party sources, including from portfolio companies of funds managed by BoCG Ventures. While taken from sources believed to be reliable, BoCG Ventures has not independently verified such information and makes no representations about the enduring accuracy of the information or its appropriateness for a given situation.

This content is provided for informational purposes only, and should not be relied upon as legal, business, investment, or tax advice. You should consult your own advisers as to those matters. References to any securities or digital assets are for illustrative purposes only, and do not constitute an investment recommendation or offer to provide investment advisory services. Furthermore, this content is not directed at nor intended for use by any investors or prospective investors, and may not under any circumstances be relied upon when making a decision to invest in any fund managed by BoCG Ventures.

Charts and graphs provided within are for informational purposes solely and should not be relied upon when making any investment decision. Past performance is not indicative of future results. The content speaks only as of the date indicated. Any projections, estimates, forecasts, targets, prospects, and/or opinions expressed in these materials are subject to change without notice and may differ or be contrary to opinions expressed by others.